Hemodynamic changes and circulating recombinant tumor necrosis factor-alpha concentrations in a patient undergoing isolated limb perfusion.
Fawcett
W J
WJ
Magill Department of Anaesthetics, England Charing Cross and Westminster Medical School, Westminster Hospital, London, UK.
Hill
S
S
Sheldon
J
J
Williams
T R
TR
Thomas
J M
JM
Riches
P
P
Gore
M E
ME
Soni
N
N
D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007378:Interleukins / Q000097:blood; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000473:pathology*; D013977:Tibia; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use
D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan